Zurich Cantonal Bank
HUMA icon

Zurich Cantonal Bank’s Humacyte HUMA Stock Holding History

Zurich Cantonal Bank’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-29,004
Closed -$49.5K – 2593
2025
Q1 		$49.5K Hold
29,004
– – ﹤0.01% 2514
2024
Q4 		$146K Buy
+29,004
New +$144K ﹤0.01% 2284
2023
Q1 		– Sell
-4,973
Closed -$10.5K – 2864
2022
Q4 		$10.5K Hold
4,973
– – ﹤0.01% 2802
2022
Q3 		$16K Hold
4,973
– – ﹤0.01% 2831
2022
Q2 		$16K Buy
+4,973
New +$27.6K ﹤0.01% 2817
2022
Q1 		– Sell
-13,230
Closed -$96K – 2772
2021
Q4 		$96K Buy
+13,230
New +$131K ﹤0.01% 2530

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Zurich Cantonal Bank's HUMA Position: Q2 2025 in Review

Zurich Cantonal Bank sold out of Humacyte (HUMA) in Q2 2025, closing a stake of 29,004 shares — an estimated $49.5K sold.

Zurich Cantonal Bank first reported a position in HUMA in Q4 2021 and held it in 6 quarters. The position peaked at $146K in Q4 2024. 156 funds tracked by Wall St. Rank hold HUMA as of Q2 2025.

  • Zurich Cantonal Bank reported no remaining Humacyte position as of Q2 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 29,004 Humacyte shares in Q2 2025, an estimated $49.5K.
  • Zurich Cantonal Bank first reported a position in Humacyte in Q4 2021 and held it in 6 quarters.
  • Zurich Cantonal Bank's Humacyte position peaked at $146K in Q4 2024.
  • 156 funds tracked by Wall St. Rank held Humacyte as of Q2 2025.

Based on Zurich Cantonal Bank's 13F filing for Q2 2025, filed 7 Aug 2025.